Clinical Trials Browser

Completed × OTHER × ADI PEG20 × Clear all

NCT03922880 2025-05-15

Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

Phase 1 Completed

Uveal Melanoma

NCT00520299 2022-10-25

Study of ADI-PEG 20 in Patients With Advanced Melanoma

Phase 1/2 Completed

31 enrolled 16 charts

Melanoma, Neoplasms, Skin Neoplasms

NCT00450372 2017-02-08

Pegylated Arginine Deiminase in Treating Patients With Metastatic Melanoma That Cannot Be Removed by Surgery

Phase 2 Completed

38 enrolled 9 charts

Melanoma